Altered mRNA levels of MOV10, A3G, and IFN-α in patients with chronic hepatitis B. (Q42216224)

18 October 2017

Altered mRNA levels of MOV10, A3G, and IFN-α in patients with chronic hepatitis B. (English)

1 reference

18 October 2017

Zhi-Wei Song

1

1 reference

18 October 2017

Yan-Xiu Ma

2

1 reference

18 October 2017

Bao-qing Fu

3

1 reference

18 October 2017

Xu Teng

4

1 reference

18 October 2017

Si-Jia Chen

5

1 reference

18 October 2017

Wei-Zhen Xu

6

1 reference

18 October 2017

Hong-Xi Gu

7

1 reference

18 October 2017

Antibiotic Resistance Surveillance Program in Portugal (ARSIP) Participants

8

1 reference

18 October 2017

language of work or name

1 reference

29 May 2014

1 reference

The Journal of Microbiology

18 October 2017

1 reference

18 October 2017

52

1 reference

18 October 2017

6

1 reference

18 October 2017

510-514

1 reference

https://scigraph.springernature.com/pub.10.1007/s12275-014-3467-8

18 October 2017

0 references

cites work

Mov10, an APOBEC3G-interacting RNA-binding protein, inhibits HIV-1 infection.

1 reference

https://api.crossref.org/works/10.1007%2FS12275-014-3467-8

Innate and adaptive immune responses in chronic hepatitis B virus infections: towards restoration of immune control of viral infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12275-014-3467-8

Hepatitis B: modern concepts in pathogenesis--APOBEC3 cytidine deaminases as effectors in innate immunity against the hepatitis B virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12275-014-3467-8

P body-associated protein Mov10 inhibits HIV-1 replication at multiple stages

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12275-014-3467-8

Perturbation of the P-body component Mov10 inhibits HIV-1 infectivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12275-014-3467-8

MOV10 RNA helicase is a potent inhibitor of retrotransposition in cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12275-014-3467-8

The 5-choice continuous performance test: evidence for a translational test of vigilance for mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12275-014-3467-8

Hypermutation of HIV-1 DNA in the Absence of the Vif Protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12275-014-3467-8

Hepatitis B infection and changes in interferon-alpha and -gamma production in patients with systemic lupus erythematosus in Taiwan.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12275-014-3467-8

The potential role of APOBEC3G in limiting replication of hepatitis B virus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12275-014-3467-8

G-to-A hypermutation in hepatitis B virus (HBV) and clinical course of patients with chronic HBV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12275-014-3467-8

Performance of sequence analysis, INNO-LiPA line probe assays and AFFIGENE assays in the detection of hepatitis B virus polymerase and precore/core promoter mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12275-014-3467-8

APOBEC-mediated interference with hepadnavirus production

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12275-014-3467-8

Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12275-014-3467-8

Inhibition of hepatitis B virus replication by APOBEC3G.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12275-014-3467-8

Massive APOBEC3 editing of hepatitis B viral DNA in cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12275-014-3467-8

Moloney leukemia virus 10 (MOV10) protein inhibits retrovirus replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12275-014-3467-8

APOBEC3G directly binds Hepatitis B virus core protein in cell and cell free systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12275-014-3467-8

Genetic editing of HBV DNA by monodomain human APOBEC3 cytidine deaminases and the recombinant nature of APOBEC3G.

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24871977

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Chronic fatigue syndrome and immune dysfunction: cause or effect?

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24871977

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Recommendations for identification and public health management of persons with chronic hepatitis B virus infection

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24871977

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S12275-014-3467-8

1 reference

18 October 2017

1 reference